Goricox 90 Tablet contains Etoricoxib 90 mg, a selective cyclooxygenase-2 (COX-2) inhibitor used primarily for the management of pain and inflammation associated with various musculoskeletal and inflammatory conditions. Etoricoxib exerts its therapeutic effects by selectively inhibiting the COX-2 enzyme, thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and fever, while sparing the COX-1 enzyme which protects the gastric mucosa. This selective action results in effective analgesia with a potentially lower risk of gastrointestinal adverse effects compared to non-selective nonsteroidal anti-inflammatory drugs (NSAIDs). Goricox 90 is indicated for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis, as well as for the relief of acute musculoskeletal pain and postoperative dental pain. The recommended dosage should be individualized based on the severity of the condition and patient response, with caution advised in patients with cardiovascular risk factors, renal impairment, or hepatic dysfunction. It is contraindicated in patients with known hypersensitivity to Etoricoxib or other NSAIDs, active peptic ulcer disease, or severe heart failure. Regular monitoring and adherence to prescribed dosages are essential to minimize potential adverse effects and ensure optimal therapeutic outcomes.

Dosage & How to Use